Featured Partners
Partners
Defence Therapeutics expands patent portfolio, bolstering innovation in cancer and vaccine therapies
Defence Therapeutics Inc. has announced the significant expansion of its patent portfolio with several crucial issuances and allowances across multiple jurisdictions.
These developments solidify Defence’s...
Inside the journey of Giuseppe Accogli: From med-tech veteran to Chiesi Group CEO
Giuseppe Accogli, Chiesi Group CEO, shares insights from his extensive med-tech career, highlighting his role in driving Chiesi's global expansion and fostering innovation.
He delves...
Dr Elias Theodorou joins Defence board of directors
Dr Elias Theodorou is a molecular biologist with over 25 years of experience in the healthcare sector. Read more here.